- Lobbying
- Lobbying by Spark Therapeutics, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Alfred Mottur | Sr Communications Counsel Senate Commerce Comm; Communications Counsel Senate Commerce Comm; Law Clerk Federal District Court Bangor, ME; Communications Counsel-Sen. Commerce Com; Law Clerk-Federal District Court-Bangor, ME |
Laura Johnson | Legislative intern - Senate HELP Committee |
Peter Goodloe | Senior Counsel, House Legislative Counsel; Health Counsel/Parliamentarian, House Committee on Energy and Commerce |
Brian McKeon | Legislative Aide - Sen Boxer; Legislative Assistant - Sen Boxer; Domestic Policy Advisor - Sen Boxer; Senior Advisor - Sen Boxer; Senior Counsel - Sen Boxer; Legislative Director - Senator Shaheen |
Zachary Pfister | LegDir Rep Larry Kissell; SenLegAsst Rep Larry Kissell; LegAsst Rep Larry Kissell; LegCorrespondent Rep Larry Kissell; LegCorrespondent Rep Brad Ellsworth; StaffAsst Rep Brad Ellsworth; LegIntern Sen Evan Bayh |
Araceli Gutierrez | Congressional Hispanic Caucus Institute Graduate Fellow, Rep. Roybal-Allard |
Nadeam Elshami | CoS, Dem. Ldr Pelosi; Comms.Dir/Sr. Adv., Dem.Ldr Nancy Pelosi; Dep. Comms. Dir/Sr. Adv., Speaker Pelosi; Sr. Comms. Adv./Dep. Comms. Dir/Spokesman/Natl Press Sec, Sen Durbin; Dep. CoS/Comms Dir/Press Sec, Rep Schakowsky; Dep Press Sec, Sen Boxer |
Jerome Murray | Chief of Staff, Rep. Stacey Plaskett; Legislative Director, Rep. G.K. Butterfield; Associate Director, Democratic Steering and Outreach Committee, Sen. Harry Reid; Legislative Director, Rep. Chaka Fattah; Staff Assistant, Rep. Chaka Fattah |
Emily Felder | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
Cate McCanless | n/a |
Sohil Khurana | n/a |
Deema Tarazi | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Pharmaceutical Issues.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate